Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Carmen De Santis
Neoadjuvant Eribulin Mesylate Following Anthracycline and Taxane in Triple Negative Breast Cancer: Results From the HOPE Study
PLoS ONE
Multidisciplinary
Related publications
PIK3CA H1047R Mutation Associated With a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated With Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Cancer Research and Treatment
Cancer Research
Oncology
Eribulin Mesylate in the Treatment of Metastatic Breast Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Triple-Negative Breast Cancer
Comparative Analysis of Different Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer
Tumors of female reproductive system
Combination Chemotherapy of Mitomycin C and Methotrexate Was Effective on Metastatic Breast Cancer Resistant to Eribulin, Vinorelbine, and Bevacizumab After Anthracycline, Taxane, and Capecitabine
Case Reports in Oncology
Oncology
Evolving Approaches to Metastatic Breast Cancer Patients Pre-Treated With Anthracycline and Taxane
BioDrugs
Medicine
Biotechnology
Pharmacology
A Phase II Study of Gemcitabine Monotherapy in Breast Cancer Patients Refractory to Anthracycline and Taxane
Cancer Research and Treatment
Cancer Research
Oncology
Risk Factors Affecting Breast Cancer-Related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane
Clinical Breast Cancer
Cancer Research
Oncology
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
